Wall Street Zen Initiates Coverage on T2 Biosystems (NASDAQ:TTOO)

Analysts at Wall Street Zen started coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a research note issued on Wednesday. The brokerage set a “sell” rating on the medical equipment provider’s stock.

T2 Biosystems Stock Down 5.6%

Shares of T2 Biosystems stock opened at $0.15 on Wednesday. The company has a fifty day moving average of $0.13 and a 200 day moving average of $0.26. T2 Biosystems has a fifty-two week low of $0.06 and a fifty-two week high of $6.80.

About T2 Biosystems

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.